Otsuka Pharmaceuticals

In a mid-day note on Wednesday, Alethia Young of Deutsche Bank downgraded shares of Avanir Pharmaceuticals Inc (NASDAQ: AVNR) to Hold from Buy. Otsuka Pharmaceuticals announced on Tuesday that it will acquire Avanir for $3.5 billion or $17 per share. Young believes that this represents a...